Comparing standard treatment of moderate to severe obstructive sleep apnoea to add-on acetazolamide treatment: An open-label randomised controlled trial
The addition of acetazolamide to CPAP therapy improves efficacy in OSA treatment parameters among moderate-to-severe OSA, reduces total and NREM AHI as well as ODI without an increase in adverse effects. With added pharmacotherapy, the combination therapy represents a potential adjunctive treatment for managing OSA.
Authors
- Deepak Sharma (ORCID: https://orcid.org/0000-0002-5497-0999)
- Mohammad Taufiqul Arif (ORCID: https://orcid.org/0000-0001-8071-3235)
- Shubhra Srivastava
- Mrityunjaya Singh
- Hemant Kumar (ORCID: https://orcid.org/0000-0003-0603-4394)
- Sachin Kumar (ORCID: https://orcid.org/0000-0002-2594-6770)
- Anurag Tripathi (ORCID: https://orcid.org/0000-0002-2289-2500)
- Ved Prakash (ORCID: https://orcid.org/0000-0002-2363-1484)
- Atul Tiwari
Institutions
- King George's Medical University (IN)
- Dr. Ram Manohar Lohia Institute of Medical Sciences (IN)
Publication Details
- Journal
- Lung India
- Published
- 2024-12-24
- DOI
- https://doi.org/10.4103/lungindia.lungindia_409_24
- Citations
- 1
- Primary Topic
- Obstructive Sleep Apnea Research
- Type
- article
- Field-Weighted Citation Impact
- 0.33